fda bans compounded semaglutide and tirzepatide Ban on GLP-1 Drugs: What to Know Are off-brand versions of popular
Description
Akkermansia muciniphila Supports GLP-1 activity, strengthens the gut barrier, promotes metabolic balance
Caution should be exercised in patients with a history of pancreatic disease, as well as in those with compromised renal or hepatic function
The use of GLP-1RA is a new therapeutic strategy that addresses both metabolic and cognitive/neuropsychiatric aspects, which is fundamentally important for the treatment of comorbid diseases.
Flu season brings questions about continuing GLP-1 therapy
Retatrutide: An investigational triple agonist (GIP, GLP-1, glucagon) studied for metabolic outcomes
